A total of 11% of RSV patients experienced a cardiac event, abnormal heart rhythm, heart failure, or ischemic heart disease.
The loss of activity is equivalent to 15% of the US population becoming completely immobile for 1 day.
Adult COVID-19 patients also infected with the flu are 4 times more likely to need mechanical ventilation and 2.4 times more likely to die.
The roadmap offers a powerful opportunity to leverage advances in vaccine science to better protect against influenza, including pandemic flu.
The Influenza Vaccines Roadmaps Initiative newsletter highlights recent news, research, and events pertaining to influenza vaccine R&D.
A database of novel vaccine candidates that are designed to provide broader and more durable protection against influenza viruses.
Help support our work on influenza. Advance the work of CIDRAP in public health preparedness and emerging infectious disease response.
Receive the latest infectious disease information.
The incubation period for the Omicron variant may be shorter than for Delta and the original SARS-CoV-2 virus, Nebraska researchers reported yesterday, based on an analysis of the first known Omicron cluster in the United States. The team reported its findings yesterday in an early online edition of Morbidity and Mortality Weekly Report (MMWR).
United States flu activity jumped again the week ending Dec 18, with eight states reporting high or very high activity and the first two pediatric flu deaths reported for the season, the US Centers for Disease Control and Prevention (CDC) said today in its regular update.
A team of pediatricians in Massachusetts has developed a new metric for capturing the range of antibiotic prescribing among pediatricians for common clinical scenarios.
COVID-19 breakthrough infections in fully vaccinated US adults substantially boosted humoral immunity and demonstrated cross-neutralization against the Delta (B1617.2) variant, despite mostly mild illness, finds a small study yesterday in JAMA.
Humoral immunity involves antibodies secreted by B cells circulating in bodily fluids.
The World Health Organization (WHO) announced yesterday that it has received more than $21 million from Saudi Arabia to support implementation of national antimicrobial resistance (AMR) action plans in several low- and middle-income countries.
A new study presented at an American Society of Health-System Pharmacists (ASHP) meeting finds that influenza vaccination rates are low for people without a regular healthcare provider, at just 20.5%, as well as among minority groups.
Vaccine coverage among American adults with a regular provider was 44.5%, according to the research, which was presented yesterday at the society's midyear conference.
US Sen. Sherrod Brown, D-Ohio, announced this week that he has reintroduced legislation to strengthen the federal response to antibiotic resistance.
During a meeting tomorrow at the Radiological Society of North America (RSNA), scientists will present data from the largest multi-institutional international study to date on brain complications of COVID-19 and share that 1 in 100 patients hospitalized with COVID-19 will likely develop complications of the central nervous system like stroke, hemorrhage, and other potentially fatal complications.
A large study of patients in Veterans Administration (VA) hospitals shows a significant increase in the use of ceftazidime-avibactam for carbapenem-resistant Enterobacterales (CRE) infections, US researchers reported today in Infection Control & Hospital Epidemiology.
Upwards of 700,000—perhaps as many as 1.6 million—US COVID-19 survivors haven't recovered their sense of smell after more than 6 months, according to a research letter yesterday in JAMA Otolaryngology-Head & Neck Surgery.